a $368 million market cap.
Furthermore they are high cost GOM and Marcellus producers.
Yeah, but the FDA publishes their schedule for most big decisions. Who is the lead on this one, Merck?
Nevertheless, I am optimistic regarding BIND. I just wish there were some recent insider buying. It is my second largest biotech holding (SCMP is first as of this week).
good news - no one is selling.
bad news - no one is buying
and a puny $90 million market cap the damage is done. One would at least expect some short covering on higher crude days.
btw - I am long SGY and only my profits in WLL and MRO are keeping me around.
Ha HA! They barely cracked $5 on 45 million shares traded Th-Fr.
45 million shares in two days and it didn't move much past $4.
Hilarious. That is positive. The stock was capitalized back then and now has three approved products that generate over $40 million in sales. The market cap is only $110 million.
No debt, pal.
You must feel lucky.
a few $7.50 are even out for March
PGNX $5 calls selling too - they report tomorrow. The biotechs have been beaten up too much.
Thanks. I put in some casino at $5.70 just in case some positive outcome is on the way. PR may be the only driver for now.
I notice that past earnings reports are erratic but this company is in a novel niche with a low market cap (which I like).
but what driver would make it beat expectations?
Go to the corporate web site. There are annual reports with balance sheets. The new annual report is being compiled. 2014 is the latest.
DVN sold 69 million shares at $18.75 last night and the stock is trading up from there and down only 4% today.
I own both WLL and MRO. I like MRO more for its solid balance sheet. I will be watching the price action closely today.
There is definitely more risk in WLL but they are hedged well.
WLL is up 7% pre market - MRO only 3.6%. And WLL was up big yesterday when MRO was not.
That huge volume yesterday held the price down.